{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:51:01Z","timestamp":1791553861182,"version":"4.3.4"},"reference-count":83,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"DFG, Deutsche Forschungsgemeinschaft","award":["RO957\/13-1"],"award-info":[{"award-number":["RO957\/13-1"]}]},{"name":"DFG, Deutsche Forschungsgemeinschaft","award":["RO3714\/4-1"],"award-info":[{"award-number":["RO3714\/4-1"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The liver, as a central metabolic organ, is systemically linked to metabolic\u2013inflammatory diseases. In the pathogenesis of the metabolic syndrome, inflammatory and metabolic interactions between the intestine, liver, and adipose tissue lead to the progression of hepatic steatosis to metabolic-dysfunction-associated steatohepatitis (MASH) and consecutive MASH-induced fibrosis. Clinical and animal studies revealed that IL-13 might be protective in the development of MASH through both the preservation of metabolic functions and Th2-polarized inflammation in the liver and the adipose tissue. In contrast, IL-13-associated loss of mucosal gut barrier function and IL-13-associated enhanced hepatic fibrosis may contribute to the progression of MASH. However, there are only a few publications on the effect of IL-13 on metabolic diseases and possible therapies to influence them. In this review article, different aspects of IL-13-associated effects on the liver and metabolic liver diseases, which are partly contradictory, are summarized and discussed on the basis of the recent literature.<\/jats:p>","DOI":"10.3390\/ijms241612884","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T10:15:48Z","timestamp":1692267348000},"page":"12884","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Interleukin-13 (IL-13)\u2014A Pleiotropic Cytokine Involved in Wound Healing and Fibrosis"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5739-5400","authenticated-orcid":false,"given":"Elke","family":"Roeb","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Justus Liebig University Giessen, Klinikstr. 33, 35392 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Rinella, M.E., Lazarus, J.V., Ratziu, V., Francque, S.M., Sanyal, A.J., Kanwal, F., Romero, D., Abdelmalek, M.F., Anstee, Q.M., and Arab, J.P. (2023). A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol., 101133.","DOI":"10.1016\/j.aohep.2023.101133"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jdv.12847","article-title":"Risk of non-alcoholic fatty liver disease in patients with psoriasis: A systematic review and meta-analysis","volume":"29","author":"Candia","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_3","first-page":"517","article-title":"Non-alcoholic fatty liver disease and psoriasis\u2014Is there a shared proinflammatory network?","volume":"19","author":"Heitmann","year":"2021","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.3748\/wjg.v27.i41.7113","article-title":"Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach","volume":"27","author":"Rivera","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1194\/jlr.R066514","article-title":"Lipid signaling and lipotoxicity in metaflammation: Indications for metabolic disease pathogenesis and treatment","volume":"57","author":"Ertunc","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/1873-3468.12742","article-title":"From chronic overnutrition to metaflammation and insulin resistance: Adipose tissue and liver contributions","volume":"591","author":"Caputo","year":"2017","journal-title":"FEBS Lett."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"9706","DOI":"10.3748\/wjg.v22.i44.9706","article-title":"Galectin-3 and IL-33\/ST2 axis roles and interplay in diet-induced steatohepatitis","volume":"22","author":"Pejnovic","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1055\/a-1880-2283","article-title":"Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs-und Stoffwechselkrankheiten (DGVS)\u2013April 2022\u2013AWMF-Registernummer: 021\u2013025","volume":"60","author":"Roeb","year":"2022","journal-title":"Z. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jceh.2022.12.005","article-title":"The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United States","volume":"13","author":"Younossi","year":"2023","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000519611","article-title":"Diagnostic and Therapy of Nonalcoholic Fatty Liver Disease: A Narrative Review","volume":"38","author":"Roeb","year":"2022","journal-title":"Visc. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/a-1986-7676","article-title":"Clinical characteristics of patients with non-alcoholic fatty liver disease (NAFLD) in Germany\u2014First data from the German NAFLD-Registry","volume":"61","author":"Geier","year":"2023","journal-title":"Z. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"726","DOI":"10.21037\/atm-20-3760","article-title":"Non-alcoholic fatty liver diseases: Current challenges and future directions","volume":"9","author":"Roeb","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Lazarus, J.V., Mark, H.E., Allen, A.M., Arab, J.P., Carrieri, P., Noureddin, M., Alazawi, W., Alkhouri, N., Alqahtani, S.A., and Anstee, Q.M. (2023). A global action agenda for turning the tide on fatty liver disease. Hepatology.","DOI":"10.1097\/HEP.0000000000000545"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1006\/cyto.1996.0184","article-title":"T cell subsets and cytokines in allergic and non-allergic children. I. Analysis of IL-4, IFN-gamma and IL-13 mRNA expression and protein production","volume":"9","author":"Koning","year":"1997","journal-title":"Cytokine"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Bernstein, Z.J., Shenoy, A., Chen, A., Heller, N.M., and Spangler, J.B. (2023). Engineering the IL-4\/IL-13 axis for targeted immune modulation. Immunol. Rev.","DOI":"10.1111\/imr.13230"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/eji.201445303","article-title":"IL-3 synergises with basophil-derived IL-4 and IL-13 to promote the alternative activation of human monocytes","volume":"45","author":"Borriello","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e12835","DOI":"10.1111\/sji.12835","article-title":"Antagonism of the interleukin 4 receptor \u03b1 promotes T(H) 1-signalling among T cells from patients with atopic dermatitis after stimulation","volume":"91","author":"Blom","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nm1332","article-title":"IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis","volume":"12","author":"Strober","year":"2006","journal-title":"Nat. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3389\/fphar.2019.01387","article-title":"The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma","volume":"10","author":"Marone","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Allgire, E., Ahlbrand, R.A., Nawreen, N., Ajmani, A., Hoover, C., McAlees, J.W., Lewkowich, I.P., and Sah, I.P. Altered fear behavior in aeroallergen house dust mite exposed C57Bl\/6 mice: A model of Th2-skewed airway inflammation. Neuroscience, 2023. in press.","DOI":"10.1016\/j.neuroscience.2023.07.022"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-3083.2001.00900.x","article-title":"CD40L-induced IL-12 production is further enhanced by the Th2 cytokines IL-4 and IL-13","volume":"53","author":"Bullens","year":"2001","journal-title":"Scand. J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/10520295.2017.1312526","article-title":"Effects of IL-13 on TGF-\u03b2 and MMP-1 in periodontitis","volume":"92","author":"Beklen","year":"2017","journal-title":"Biotech. Histochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1126\/science.1095336","article-title":"Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation","volume":"304","author":"Zhu","year":"2004","journal-title":"Science"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.4049\/jimmunol.164.5.2738","article-title":"Expression and contribution of endogenous IL-13 in an experimental model of sepsis","volume":"164","author":"Matsukawa","year":"2000","journal-title":"J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Raabe, J., Kaiser, K.M., ToVinh, M., Finnemann, C., Lutz, P., Hoffmeister, C., Bischoff, J., Goeser, F., Kaczmarek, D.J., and Glowka, T.R. (2023). Identification and characterisation of a hepatic IL-13 producing ILC3-like population potentially involved in liver fibrosis. Hepatology.","DOI":"10.1097\/HEP.0000000000000350"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1089\/107999099312993","article-title":"Immunoregulatory roles of interleukin-13 in cattle","volume":"19","author":"Trigona","year":"1999","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.0105-2896.2004.00210.x","article-title":"Opposing roles for IL-13 and IL-13 receptor alpha 2 in health and disease","volume":"202","author":"Wynn","year":"2004","journal-title":"Immunol. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.55133\/eji.290417","article-title":"Role of IL-17A in enhancing liver fibrosis induced by TGF-\u03b21 and IL-13 in Schistosoma mansoni infected mice","volume":"29","author":"Zaalouk","year":"2022","journal-title":"Egypt J. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.4049\/jimmunol.2100655","article-title":"IL-13 Controls IL-33 Activity through Modulation of ST2","volume":"207","author":"Zhang","year":"2021","journal-title":"J. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ajhg.2008.09.012","article-title":"Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes","volume":"83","author":"Yuan","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Maggi, L., Camelo, G.M.A., Rocha, I.C., Pereira Alves, W., Moreira, J.M.P., Almeida Pereira, T., Tafuri, W.L., Rabelo, \u00c9.M.L., Correa, A., and Ecco, R. (2023). Role of the IL-33\/ST2 Activation Pathway in the Development of the Hepatic Fibrosis Induced by Schistosoma mansoni Granulomas in Mice. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241210237"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/ijo.2015.52","article-title":"Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice","volume":"39","author":"Darkhal","year":"2015","journal-title":"Int. J. Obes."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Hahn, L., Helmrich, N., Herebian, D., Mayatepek, E., Drebber, U., Domann, E., Olejniczak, S., Weigel, M., Hain, T., and Rath, T. (2020). IL-13 as Target to Reduce Cholestasis and Dysbiosis in Abcb4 Knockout Mice. Cells, 9.","DOI":"10.3390\/cells9091949"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"C2029","DOI":"10.1152\/ajpcell.2001.281.6.C2029","article-title":"Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-gamma","volume":"281","author":"Ahdieh","year":"2001","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1128\/IAI.74.3.1471-1479.2006","article-title":"Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity","volume":"74","author":"Reiman","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3389\/fimmu.2018.01979","article-title":"Emerging Role of HMGB1 in the Pathogenesis of Schistosomiasis Liver Fibrosis","volume":"9","author":"Vicentino","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1128\/AAC.01936-13","article-title":"Silymarin reduces profibrogenic cytokines and reverses hepatic fibrosis in chronic murine schistosomiasis","volume":"58","author":"Dutra","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"645717","DOI":"10.3389\/fimmu.2021.645717","article-title":"The Protective Effects of IL-31RA Deficiency During Bleomycin-Induced Pulmonary Fibrosis","volume":"12","author":"Yombo","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1186\/s13071-015-1197-3","article-title":"Hepatic myofibroblasts derived from Schistosoma mansoni-infected mice are a source of IL-5 and eotaxin: Controls of eosinophil populations in vitro","volume":"8","author":"Paiva","year":"2015","journal-title":"Parasit Vectors"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"155701","DOI":"10.1016\/j.cyto.2021.155701","article-title":"Eosinophils participate in modulation of liver immune response and tissue damage induced by Schistosoma mansoni infection in mice","volume":"149","author":"Rodrigues","year":"2022","journal-title":"Cytokine"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"eaal3694","DOI":"10.1126\/scitranslmed.aal3694","article-title":"Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-\u03b2","volume":"9","author":"Hart","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ni.1962","article-title":"The expanding family of innate lymphoid cells: Regulators and effectors of immunity and tissue remodeling","volume":"12","author":"Spits","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1177\/1753425915586074","article-title":"Type 1 innate lymphoid cells contribute to the pathogenesis of chronic hepatitis B","volume":"21","author":"Yang","year":"2015","journal-title":"Innate immunity"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/CIRCHEARTFAILURE.113.001020","article-title":"Interleukin-13 deficiency aggravates healing and remodeling in male mice after experimental myocardial infarction","volume":"7","author":"Hofmann","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1096\/fj.201801285R","article-title":"IL-13 signaling through IL-13 receptor \u03b12 mediates airway epithelial wound repair","volume":"33","author":"Yang","year":"2019","journal-title":"FASEB J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00403-019-01972-3","article-title":"The IL-4\/IL-13 axis in skin fibrosis and scarring: Mechanistic concepts and therapeutic targets","volume":"312","author":"Nguyen","year":"2020","journal-title":"Arch. Dermatol. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1039\/D2BM00828A","article-title":"Destructive fibrotic teamwork: How both microenvironment stiffness and profibrotic interleukin 13 impair alveolar macrophage phenotype and function","volume":"10","author":"Bomb","year":"2022","journal-title":"Biomater. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s00383-022-05238-4","article-title":"IL13 and periostin in active fibrogenic areas of the extrahepatic bile ducts in biliary atresia patients","volume":"38","author":"Sengoku","year":"2022","journal-title":"Pediatr. Surg. Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.gastro.2005.05.002","article-title":"Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution","volume":"129","author":"Heller","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1038\/mi.2008.46","article-title":"Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: Effect of pro-inflammatory interleukin-13 on epithelial cell function","volume":"1","author":"Heller","year":"2008","journal-title":"Mucosal Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/mi.2017.52","article-title":"Tricellulin is regulated via interleukin-13-receptor \u03b12, affects macromolecule uptake, and is decreased in ulcerative colitis","volume":"11","author":"Krug","year":"2018","journal-title":"Mucosal Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Long, X., Chen, Q., Zhao, J., Rafaels, N., Mathias, P., Liang, H., Potee, J., Campbell, M., Zhang, B., and Gao, L. (2015). An IL-13 promoter polymorphism associated with liver fibrosis in patients with Schistosoma japonicum. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135360"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"613468","DOI":"10.3389\/fimmu.2021.613468","article-title":"The Genetics of Human Schistosomiasis Infection Intensity and Liver Disease: A Review","volume":"12","author":"Mewamba","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Aemero, M., Boissier, J., Climent, D., Mon\u00e9, H., Mouahid, G., Berhe, N., and Erko, B. (2015). Genetic diversity, multiplicity of infection and population structure of Schistosoma mansoni isolates from human hosts in Ethiopia. BMC Genet., 16.","DOI":"10.1186\/s12863-015-0297-6"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1165\/rcmb.2022-0021OC","article-title":"Antifibrotic Drug Nintedanib Inhibits CSF1R to Promote IL-4-associated Tissue Repair Macrophages","volume":"68","author":"Watson","year":"2023","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1172\/JCI25711","article-title":"ERK1\/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo","volume":"116","author":"Lee","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s11011-020-00596-1","article-title":"Interleukin-13 ameliorates postischemic hepatic gluconeogenesis and hyperglycemia in rat model of stroke","volume":"35","author":"Liao","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1172\/JCI64941","article-title":"Direct control of hepatic glucose production by interleukin-13 in mice","volume":"123","author":"Stanya","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1182\/blood-2011-02-339911","article-title":"Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology","volume":"119","author":"Pello","year":"2012","journal-title":"Blood"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1074\/jbc.M110.169367","article-title":"The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1)","volume":"286","author":"Louafi","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1111\/cas.14066","article-title":"Interleukin-13 and its signaling pathway is associated with obesity-related colorectal tumorigenesis","volume":"110","author":"Matsui","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/00365513.2021.1876245","article-title":"Chronic inflammation involves CCL11 and IL-13 to facilitate the development of liver cirrhosis and fibrosis in chronic hepatitis B virus infection","volume":"81","author":"Wong","year":"2021","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1440-1746.2008.05531.x","article-title":"Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection","volume":"23","author":"Shi","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jtcme.2021.04.004","article-title":"Genistein and exercise treatment reduced NASH related HDAC3, IL-13 and MMP-12 expressions in ovariectomized rats fed with high fat high fructose diet","volume":"11","author":"Witayavanitkul","year":"2021","journal-title":"J. Tradit. Complement. Med."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"El-Derany, M.O. (2020). Polymorphisms in Interleukin 13 Signaling and Interacting Genes Predict Advanced Fibrosis and Hepatocellular Carcinoma Development in Non-Alcoholic Steatohepatitis. Biology, 9.","DOI":"10.3390\/biology9040075"},{"key":"ref_67","first-page":"e25301","article-title":"STAT6 and lung inflammation","volume":"2","author":"Walford","year":"2013","journal-title":"Jakstat"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.4049\/jimmunol.181.7.4656","article-title":"Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model","volume":"181","author":"Shimamura","year":"2008","journal-title":"J. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0002-9440(10)65208-X","article-title":"IL-13 activates STAT6 and inhibits liver injury induced by ischemia\/reperfusion","volume":"155","author":"Yoshidome","year":"1999","journal-title":"Am. J. Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Russi, A.E., Shivakumar, P., Luo, Z., and Bezerra, J. (2023). Plasticity between ILC2 subsets and amphiregulin expression regulate epithelial repair in biliary atresia. Hepatology.","DOI":"10.1097\/HEP.0000000000000418"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1038\/s41467-022-33171-6","article-title":"Liver group 2 innate lymphoid cells regulate blood glucose levels through IL-13 signaling and suppression of gluconeogenesis","volume":"13","author":"Fujimoto","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1042\/CS20190961","article-title":"IL-13-driven alterations in hepatic cholesterol handling contributes to hypercholesterolemia in a rat model of minimal change disease","volume":"134","author":"Low","year":"2020","journal-title":"Clin. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.immuni.2016.06.009","article-title":"Interleukin-13 Activates Distinct Cellular Pathways Leading to Ductular Reaction, Steatosis, and Fibrosis","volume":"45","author":"Gieseck","year":"2016","journal-title":"Immunity"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1111\/jcmm.17761","article-title":"Interleukin-13 contributes to the occurrence of oral submucosal fibrosis","volume":"27","author":"Wang","year":"2023","journal-title":"J. Cell Mol. Med."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Arndt, L., Lindhorst, A., Neugebauer, J., Hoffmann, A., Hobusch, C., Alexaki, V.I., Ghosh, A., Bl\u00fcher, M., Wolfrum, C., and Gla\u00df, M. (2023). The Role of IL-13 and IL-4 in Adipose Tissue Fibrosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065672"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e157091","DOI":"10.1172\/jci.insight.157091","article-title":"IL-13RA2 downregulation in fibroblasts promotes keloid fibrosis via JAK\/STAT6 activation","volume":"8","author":"Chao","year":"2023","journal-title":"JCI Insight"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1172\/JCI73742","article-title":"Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation","volume":"124","author":"Li","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.22934","article-title":"The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis","volume":"50","author":"Weng","year":"2009","journal-title":"Hepatology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ebiom.2018.01.028","article-title":"IL-4 Receptor Alpha Signaling through Macrophages Differentially Regulates Liver Fibrosis Progression and Reversal","volume":"29","author":"Weng","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2119\/molmed.2014.00178","article-title":"Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis","volume":"21","author":"Jeftic","year":"2015","journal-title":"Mol. Med."},{"key":"ref_81","first-page":"7209872","article-title":"Serum Levels of Interleukin-13 Increase in Subjects with Insulin Resistance but Do Not Correlate with Markers of Low-Grade Systemic Inflammation","volume":"2018","author":"Palomera","year":"2018","journal-title":"J. Diabetes Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1478-3231.2005.01087.x","article-title":"Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells","volume":"25","author":"Sugimoto","year":"2005","journal-title":"Liver Int."},{"key":"ref_83","unstructured":"Tralokinumab (2012). LiverTox: Clinical and Research Information on Drug-Induced Liver Injury."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/16\/12884\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:35:39Z","timestamp":1760128539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/16\/12884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":83,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["ijms241612884"],"URL":"https:\/\/doi.org\/10.3390\/ijms241612884","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,17]]}}}